What is the Zion study?
For adults with COPD
This study is investigating the medication solrikitug for its safety and effective treatment of COPD in adults. This drug works by blocking a chain reaction in the immune system that contributes to inflammation, which can lead to a flare-up.
How the study works
Qualifying participants will be enrolled at a local study site, where healthcare professionals will oversee the under-the-skin injection of either the study drug or a placebo. This study takes place over 10 visits to the study site. The total time, including follow-up, is 28 weeks.
Interested in learning more? Take the survey and find out if you are prequalified in just minutes.
Living with COPD
Do you have difficulty breathing?
COPD can cause shortness of breath, wheezing, chronic coughing, and frequent mucus buildup in the lungs. Any of these symptoms can stand in the way of a great day or a good night's sleep.
Does the fatigue impact regular activity?
COPD can also lead to fatigue and low energy, making it harder to engage in normal daily activities.
Is COPD holding you back?
Other symptoms of COPD may include being more prone to infections or other illnesses, having to limit your exposure to crowds, or more frequent trips to the healthcare provider.
This clinical study is being offered in our Houston, Texas market and is investigating a potential treatment that may help reduce some symptoms of COPD. To find out how you may be able to participate, click the button below.
Who is eligible?
Is our clinical study for COPD right for you?
Adults between the ages of 40 and 75
Diagnosed with COPD within the last 12 months
No history of other chronic diseases
Find out in minutes!
If you're interested in participating in our COPD study, take the brief survey below. You'll find out right away if you are prequalified, and what will happen next.
Copyright © 2025 Axsendo Clinical Research, LLC | All Rights Reserved
